The lantibiotic mersacidin inhibits peptidoglycan biosynthesis at the level of transglycosylation

European Journal of Biochemistry

Volumn 246, Issue 1, 1997, Pages 193-199

  Brötz, Heike ^a   Bierbaum, Gabriele ^a   Reynolds, Peter E ^b   Sahl, Hans Georg ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Actagardine; Inhibition of transglycosylation; Lantibiotic; Mersacidin; Peptidoglycan biosynthesis

Indexed keywords

LANTIBIOTIC; MERSACIDIN; PEPTIDOGLYCAN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACILLUS MEGATERIUM; BACTERICIDAL ACTIVITY; CROSS LINKING; DOSE RESPONSE; ENTEROCOCCUS FAECALIS; GENE CLUSTER; GLYCOSYLATION; IN VITRO STUDY; PRIORITY JOURNAL;

EID: 0030969611     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-1033.1997.t01-1-00193.x     Document Type: Article

References (36)

1. Sahl, H.-G., Jack, R. W. & Bierbaum, G. (1995) Biosynthesis and biological activities of lantibiotics with unique post-translational modifications. Eur. J. Biochem. 230, 827-853.
2. Chatterjee, S., Chatterjee, S., Lad, S. J., Phansalkar, M. S., Rupp, R. H., Ganguli, B. N., Fehlhaber, H.-W. & Kogler, H. (1992) Mersacidin, a new antibiotic from Bacillus: fermentation, isolation, purification and chemical characterization. J. Antibiot. 45, 832-838.
3. Bierbaum, G., Brötz, H., Koller, K.-P. & Sahl, H.-G. (1995) Cloning, sequencing and production of the lantibiotic mersacidin. FEMS Microbiol. Lett. 127, 121-126.
4. Brötz, H., Bierbaum, G., Markus, A., Molitor, H. & Sahl, H.-G. (1995) Mode of action of the lantibiotic mersacidin: inhibition of peptidoglycan biosynthesis via a novel mechanism? Antimicrob. Agents Chemother. 39, 714-719.
5. 2, and structural revision of duramycin and cinnamycin, in Nisin und novel lantibiotics (Jung, G. & Sahl, H.-G., eds) pp. 131-140, Escom, Leiden.
6. Sahl, H.-G. (1991) Pore formation in bacterial membranes by cationic lantibiotics, in Nisin and novel lantibiotics (Jung, G. & Sahl, H.-G., eds) pp. 347-358, Escom, Leiden.
7. Molitor, E., Kluczny, C., Brötz, H., Bierbaum, G., Jack, R. & Sahl, H.-G. (1996) Effects of the lantibiotic mersacidin on the morphology of staphylococci. Zentralbl. Bakteriol. 284, 318-328.
8. Chatterjee, S., Chatterjee, D. K., Jani, R. H., Blumbach, J., Ganguli, B. N., Kiesel, N., Limbert, M. & Seibert, G. (1992) Mersacidin, a new antibiotic from Bacillus: in vitro and in vivo antibacterial activity, J. Antibiot. 45, 839-845.
9. Bierbaum, G. & Sahl, H.-G. (1987) Autolytic system of Staphylococcus simulans 22: influence of cationic peptides on activity of N-acetylmuramoyl-L-alanine amidase. J. Bacteriol. 169, 5452-5458.
10. Kohlrausch, U. & Höltje, J.-V. (1991) One-step purification procedure for UDP-N-acetylmuramyl-peptide murein precursors from Bacillus cereus, FEMS Microbiol. Lett. 78, 253-258.
11. Reynolds, P. E. (1971) Peptidoglycan synthesis in bacilli I. Effect of temperature on the in vitro system from Bacillus megaterium and Bacillus stearothermophilus, Biochim. Biophys. Acta 237, 239-254.
12. Kornblum, J., Hartman, B. J., Novick, R. P. & Tomasz, A. (1986) Conversion of a homogeneously methicillin-resistant strain of Staphylococcus aureus to heterogeneous resistance by Tn551-mediated insertional inactivation. Eur. J. Clin. Microbiol. 5, 714-718.
13. Berger-Bachi, B., Barberis-Maino, L., Strässle, A. & Kayser, F. H. (1989) FemA, a host-mediated factor essential for methicillin resistance in Staphylococcus aureus: molecular cloning and characterization, Mol. Gen. Genet. 219, 263-269.
14. Maidhof, H., Reinicke, B., Blümel, P., Berger-Bächi, B. & Labischinski, H. (1991) femA, which encodes a factor essential for expression of methicillin resistance, affects glycine content of peptidoglycan in methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains, J. Bacteriol. 173, 3507-3513.
15. Henze, U., Sidow, T., Wecke, J., Labischinski, H. & Berger-Bächi, B. (1993) Influence of femB on methicillin resistance and peptidoglycan metabolism in Staphylococcus aureus, J. Bacteriol. 175, 1612-1620.
16. Leclercq, R., Derlot, E., Duval, J. & Courvalin, P. (1988) Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium, N. Engl. J. Med. 319, 157-161.
17. Weil, H.-P., Beck-Sickinger, A. G., Metzger, J., Stevanovic, S., Jung, G., Josten, M. & Sahl, H.-G. (1990) Biosynthesis of the lantibiotic Pep5. Isolation and characterization of a prepeptide containing dehydroamino acids. Eur. J. Biochem. 194, 217-223.
18. Sahl, H.-G., Grossgarten, M., Widger, W. R., Cramer, W. A. & Brandis, H. (1985) Structural similarities of the staphylococcin-like peptide Pep-5 to the peptide antibiotic nisin, Antimicrob. Agents Chemother. 27, 836-840.
19. Stranden, A. M., Ehlert, K., Labischinski, H. & Berger-Bächi, B. (1997) Cell wall monoglycine cross-bridges and methicillin hypersusceptibility in a femAB null mutant of methicillin-resistant Staphylococcus aureus. J. Bacteriol. 179, 9-16.
20. Somma, S., Merati, W. & Parenti, F. (1977) Gardimycin, a new antibiotic inhibiting peptidoglycan synthesis. Antimicrob. Agents Chemother. 11, 396-401.
21. Siewert, G. & Strominger, J. L. (1967) Bacitracin: an inhibitor of the dephosphorylation of lipid pyrophosphate, an intermediate in biosynthesis of the peptidoglycan of bacterial cell walls. Proc. Natl Acad Sci. USA 57, 767-773.
22. Van Heijenoort, Y., Derrien, M. & van Heijenoort, J. (1978) Polymerization by transglycosylation in the biosynthesis of the peptidoglycan of Escherichia coli K12 and its inhibition by antibiotics. FEBS Lett. 89, 141-144.
23. Tipper, D. J. & Strominger, J. L. (1965) Mechanism of action of penicillins: a proposal based on their structural similarity to acylD-alanyl-D-alanine. Proc. Natl Acad. Sci. USA 54, 1133-1141.
24. Somner, E. A. & Reynolds, P. E. (1990) Inhibition of peptidoglycan biosynthesis by ramoplanin, Antimicrob. Agents Chemother. 34, 413-419.
25. Tamura, G., Sasaki, T., Matsuhashi, M., Takatsuki, A. & Yamasaki, M. (1976) Tunicamycin inhibits the formation of lipid intermediate in cell-free peptidoglycan synthesis of bacteria, Agr. Biol. Chem. 40, 447-449.
26. Matsuhashi, M., Dietrich, C. P. & Strominger, J. L. (1967) Biosynthesis of the peptidoglycan of bacterial cell walls III. The role of soluble ribonucleic acid and of lipid intermediates in glycine incorporation in Staphylococcus aureus. J. Biol. Chem. 242, 3191-3206.
27. Fuchs-Cleveland, E. & Gilvarg, C. (1976) Oligomeric intermediate in peptidoglycan biosynthesis in Bacillus megaterium, Proc. Natl Acad. Sci. USA 73, 4200-4204.
28. Reynolds, P. E. (1989) Structure, biochemistry and mechanism of action of glycopeptide antibiotics. Eur. J. Clin. Microbiol. 8, 943-950.
29. Bugg, T. D. H., Wright, G. D., Dutka-Malen, S., Arthur, M., Courvalin, P. & Walsh, C. T. (1991) Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA, Biochemistry 30, 10408-10415.
30. Arthur, M., Reynolds, P. E., Depardieu, F., Evers, S., Dutka-Malen, S., Quintiliani, R. Jr & Courvalin, P. (1996) Mechanisms of glycopeptide resistance in enterococci, J. Infect. 32, 11-16.
31. Arthur, M., Molinas, C. & Courvalin, P (1992) The VanS-VanR two-component regulatory system controls synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147, J. Bacteriol. 174, 2582-2591.
32. Reynolds, P. E. (1961) Studies on the mode of action of vancomycin, Biochim. Biophys. Acta 52, 403-405.
33. Huber, G. & Nesemann, G. (1968) Moenomycin, an inhibitor of cell wall synthesis, Biochem. Biophys. Res. Commun. 30, 7-13.
34. Park, J. T. (1952) Uridine-5′-pyrophosphate derivatives. I. Isolation from Staphylococcus aureus, J. Biol. Chem. 194, 877-884.
35. 13C-NMR assignments and revised primary structure, Eur. J. Biochem. 228, 786-797.
36. Van Heijenoort. J., van Heijenoort, Y. & Welzel. P. (1988) Moenomycin: Inhibitor of peptidoglycan polymerization in Escherichia coli, in Antibiotic inhibition of bacterial cell surface assembly and function (Actor, P., Daneo-Moore, L., Higgins, M. L., Salton, M. R. J. & Shockman, G. D., eds) pp. 549-557, American Society for Microbiology, Washington D. C.